Mr. Nils Bohlin is the Vice President of Arthur D. Little Nordic and a founder of the firm's activities in Sweden. He is based in the Stockholm office where he leads the Nordic Life Science practice. His work includes corporate and business unit strategy, organisation design and development, business planning for large, medium and small companies in the Nordic Life Science sector. Mr. Bohlin is a frequent speaker and lecturer on strategic issues in the Life Science sector and is engaged in the development of regional clusters in biotechnology. He is co-author of the international best sellers Third Generation R&D, The Innovation Premium and the recently published book regarding the issue of how to ensure growth in the Swedish Economy, "Växa Snabbare". He holds an MBA from INSEAD, a M.Sc. in Chemical Engineering from Chalmers and a Bachelor of Humanities from the University of Gothenburg.

John W. Brennan is Managing Director of Arthur D. Little, Inc. leading the firm’s management and technology consulting businesses in the United States, Canada, and Latin America.

Mr. Brennan began his career locating venture-capital financing for early-stage technology firms and developing their growth strategies through to Initial Public Offerings (IPOs).

In 1989, Mr. Brennan joined Arthur D. Little and spent the next decade in a variety of management consulting positions leading major corporate- and technology-based strategic initiatives across North America, Latin America, Europe and Asia.

Mr. Brennan left the firm in 1998 to become Senior Vice President of Corporate Development at Protocare, Inc. as well as President and Head of R&D at ReasonEdge Technologies, Inc.

In January 2004, Mr. Brennan returned to Arthur D. Little where he serves as an Officer of the Company and a Member of the Board of Directors.

Since 2004, Mr. Brennan has led the Technology and Innovation business in North America and has also served as the Global Leader of ADL’s Healthcare, Consumer, and Life Sciences Practice. Mr. Brennan specializes in technology innovation and product commercialization through the development and implementation of technology, corporate, and commercial marketing strategies. More specifically, Mr. Brennan’s expertise lies in new market entry strategy, R&D portfolio management, technology strategy formulation, innovation management, technology assessment, supply chain management, franchise strategy development, and product launch planning and implementation.

Mr. Brennan has structured, negotiated and/or advised senior executives and Boards of Directors as well as private equity investors on over $5 Billion of transactions providing asset valuation, deal structure, and due-diligence advisory services related to mergers, acquisitions, technology licensing, joint ventures, and strategic alliances. He has significant expertise in the financing, growth and development of early-stage technology ventures as well as successful post-merger integration expertise.

Mr. Brennan holds Masters degrees from Harvard University and Northeastern University as well as a BA from the College of the Holy Cross.